Carisma Therapeutics Inc. Accrued Liabilities, Current
Carisma Therapeutics Inc. had Accrued Liabilities, Current of $1.09 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-11-12
- 2025-09-30: Accrued Liabilities, Current $1.09M.
- 2025-06-30: Accrued Liabilities, Current $2.53M.
- 2025-03-31: Accrued Liabilities, Current $4.71M.
- 2024-12-31: Accrued Liabilities, Current $7.45M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.09M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.53M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.71M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $7.45M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $4.54M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $9.24M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.73M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $7.66M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $7.03M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $9.61M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $10.19M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $10.36M 10-K · filed 2024-04-01 | $29.64M 10-K · filed 2023-02-28 |
| 2022-09-30 | $33.80M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $29.85M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $7.28M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $8.26M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $8.19M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $5.30M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.54M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.97M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $7.70M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.87M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.89M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.17M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $6.35M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.63M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.23M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $4.75M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $5.17M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.22M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.85M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.81M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $2.92M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $2.49M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.90M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.77M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $2.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.15M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $491.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.79M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $1.15M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $618.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.33M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $1.99M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $1.66M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.14M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $457.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $850.00K 10-K · filed 2015-03-06 |